Event Type
Disclosure
Voluntary
Variant
8-K
. Other Events On February 11, 2026, the Company issued a press-release over Globe Newswire, enclosed hereto as Exhibit 99.1, under the title: Bioxytran Reports
Financial Statements and Exhibits. Exhibit Number Description 99.1 * Press Release dated February 11, 2026 entitled “Bioxytran Reports Positive Phase 2 Results